GLP-1 Digest: Latest Research and Clinical Updates May 06, 2
Comments Off on GLP-1 Digest: Latest Research and Clinical Updates May 06, 2
May 6, 2026
Clinical Takeaway GLP-1 receptor agonists have demonstrated substantial clinical efficacy across multiple indications, from weight management to inflammatory bowel disease, while simultaneously generating significant returns on research and development…
GLP-1 Receptor Agonist Evidence: Beyond Obesity & Diabetes
Comments Off on GLP-1 Receptor Agonist Evidence: Beyond Obesity & Diabetes
April 13, 2026
The EVOKE trial investigates oral semaglutide cognitive outcomes in early Alzheimer’s disease. This GLP-1 receptor agonist evidence expands understanding beyond obesity and diabetes. Results inform clinical decisions on semaglutide’s neuroprotective…